Incorporating Interwoven Stenting and Multi-Modality Techniques into the treatment of Critical Limb Ischemia

Incorporating Interwoven Stenting and Multi-Modality Techniques into the treatment of Critical Limb Ischemia

On-Demand Webcast


D. Chris Metzger, MD
Director of Cardiac and Peripheral Vascular Cath Labs, Medical Director Clinical Research
Ballad Health System CVA Heart and Vascular Institute
Wake Forest Medical Center
Kingsport, Tennessee

Jihad A. Mustapha, MD, FACC, FSCAI
Co-founder and CEO
Advanced Cardiac & Vascular Centers for Amputation Prevention
Michigan State University College of Osteopathic Medicine
Grand Rapids, Michigan

George Pliagas, MD, FACS, FRCSC
Vascular Surgery
Advanced Cardiac & Vascular Centers for Amputation Prevention-Las Vegas
Knoxville, Tennessee

Lawrence Garcia, MD
Chief, Section, Interventional Cardiology and Vascular Interventions
Steward St. Elizabeth's Medical Center
Tufts University School of Medicine
Boston, Massachusetts

Bryan Fisher, Sr., MD
Chief of Vascular Surgery
Centennial Medical Center
Nashville, TN


Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email


The Amputation Prevention Symposium (AMP) is designed for interventional cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, nurses, vascular technologists, and cardiovascular catheterization laboratory team members.


After attending this session, participants should be able to:

  • Treat complex chronic total occlusions in tibial and pedal arterial vessels in the patient with CLI.
  • Describe tips and tricks for safe and effective surgical and endovascular treatment of CLI from access to closure.
  • Describe current wire, catheter, balloon, crossing, atherectomy, re-entry, and closure devices available for treatment of CLI, and describe mechanism of action and when most appropriate to utilize.

To be eligible for documentation of credit, participants must complete the educational activity, complete the post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who completed the live verson of this activity are not eligible to receive credit for this on-demand webcast.

Release Date: August 31, 2020
Expiration Date: August 31, 2021
Estimated time to complete: 1 hour

There is no fee associated with this activity.


NACCME would like to thank the following company who has supported the " Incorporating Interwoven Stenting and Multi-Modality Techniques into the treatment of Critical Limb Ischemia" through educational grants and/or in-kind support: Abbott Vascular


 In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1 contact hour. Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.


“Incorporating Interwoven Stenting and Multi-Modality Techniques into the treatment of Critical Limb Ischemia” taking place on August 31, 2020 to August 31, 2021 has been approved for 1 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). Reference #: AVIR200902R. The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).


NACCME is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.


This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.


NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Chris Bolwell, Samantha Conforti, Josh Hartman, MaryEllen Fama, Caitlin Eastman and Colleen Waters. 

Chris Bolwellis a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.


The faculty has reported the following:

  • D. Chris Metzger, MD: Speakers Bureau: Abbott Vascular, Endologix, Tri Vascular, CSI, Medtronic, Boston Scientific
  • Jihad A. Mustapha, MD, FACC, FSCAI: Consultant: BD Bard, Boston Scientific, Cardiovascular Systems, Inc, Medtronic, Philips, PQ Bypass, Terumo; Research: Boston Scientific, LimFlow, PQ Bypass; Equity Ownership and Board Member: CardioFlow; Chief Medical Officer: Micro Medical
  • George A. Pliagas, MD, FACS, FRCSC: Consultant/Faculty: Cardiovascular Systems Inc, Cook, Medtronic, Philips; Stockholder: Penumbra
  • Lawrence Garcia, MD: Consultant: Abbott, BSC, Philips, Medtronic; Major Stock Shareholder: CV Ingenuity, Essential Medical, Syntervention, Tissue Gen, Transit Medical, Primacea, Orchestra, Cagent, R3; Other Financial or Material Support: Innovative Vascular Partners Consulting, LLC (founder)
  • Bryan Fisher, Sr., MD: Consultant: Philips, Shockwave, Cordis, Abbott

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.